Potential causes include hypersensitivity reactions, injection site reactions, or underlying cardiovascular, renal, or hepatic conditions
As a GLP-1 receptor agonist , tirzepatide enhances insulin secretion in response to elevated blood glucose levels, suppresses inappropriate glucagon release, slows gastric emptying, and reduces appetite through central nervous system effects
You'll also need proof of your GLP-1 drug prescription and usage, as well as documentation of all related expenses, lost wages, and how your injury has impacted your daily life
If you are struggling with the transition, you might consider how targeted nutrition can support your body
A standard approach involves injection for the protocol period followed by an equivalent off period